Intermediate-Risk Patients With Pulmonary Embolism Benefit From Clot-Busting Drug

The clot-busting drug tenecteplase prevents death or circulatory collapse in a subgroup of patients with a blood clot in the lungs and appears to be especially useful in patients younger than 75, according to research presented at the American College of Cardiology's 62nd Annual Scientific Session. Pulmonary embolism occurs when part of a blood clot in a vein breaks off and travels to the lungs. It is fatal about 10 percent of the time, killing between 60,000 and 100,000 Americans each year...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/8UngfxkWzyw/257576.php

news auto sport medical